These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 37577224)

  • 1. Noninvasive Fibrosis Assessment in Chronic Hepatitis C Infection: An Update.
    Bojanic K; Bogojevic MS; Vukadin S; Sikora R; Ivanac G; Lucic NR; Smolic M; Tabll AA; Wu GY; Smolic R
    J Clin Transl Hepatol; 2023 Oct; 11(5):1228-1238. PubMed ID: 37577224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound Shear Wave Elastography for Liver Disease. A Critical Appraisal of the Many Actors on the Stage.
    Piscaglia F; Salvatore V; Mulazzani L; Cantisani V; Schiavone C
    Ultraschall Med; 2016 Feb; 37(1):1-5. PubMed ID: 26871407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitations of non-invasive tests for assessment of liver fibrosis.
    Patel K; Sebastiani G
    JHEP Rep; 2020 Apr; 2(2):100067. PubMed ID: 32118201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive Assessment of Fibrosis Regression in Hepatitis C Virus Sustained Virologic Responders.
    Trivedi HD; Lin SC; T Y Lau D
    Gastroenterol Hepatol (N Y); 2017 Oct; 13(10):587-595. PubMed ID: 29391861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological Tests Do Not Predict Residual Fibrosis in Hepatitis C Cirrhotics with a Sustained Virological Response to Interferon.
    D'Ambrosio R; Degasperi E; Aghemo A; Fraquelli M; Lampertico P; Rumi MG; Facchetti F; Grassi E; Casazza G; Rosenberg W; Bedossa P; Colombo M
    PLoS One; 2016; 11(6):e0155967. PubMed ID: 27304619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive Assessment of Liver Fibrosis By Transient Elastography and FIB4/APRI for Prediction of Treatment Response in Chronic Hepatitis C-An Experience from a Tertiary Care Hospital.
    Taneja S; Tohra S; Duseja A; Dhiman RK; Chawla YK
    J Clin Exp Hepatol; 2016 Dec; 6(4):282-290. PubMed ID: 28003717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of liver stiffness measurement, acoustic radiation force impulse measurements, and noninvasive fibrosis markers after direct-acting antivirals for hepatitis C virus G4 recurrence post living donor liver transplantation: Egyptian cohort.
    Alem SA; Said M; Anwar I; Abdellatif Z; Elbaz T; Eletreby R; AbouElKhair M; El-Serafy M; Mogawer S; El-Amir M; El-Shazly M; Hosny A; Yosry A
    J Med Virol; 2018 Sep; 90(9):1508-1515. PubMed ID: 29718546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive assessment of liver fibrosis in children with chronic hepatitis C: Shear wave elastography and APRI versus liver biopsy.
    Galal SM; Soror SM; Hussien O; Moustafa EF; Hassany SM
    Arab J Gastroenterol; 2020 Dec; 21(4):253-259. PubMed ID: 33041193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver Fibrosis in Human Immunodeficiency Virus (HIV)-Hepatitis C Virus (HCV) Coinfection Before and After Sustained Virologic Response: What Is the Best Noninvasive Marker for Monitoring Regression?
    Kronfli N; Young J; Wang S; Cox J; Walmsley S; Hull M; Cooper C; Martel-Laferriere V; Wong A; Pick N; Klein MB;
    Clin Infect Dis; 2021 Aug; 73(3):468-477. PubMed ID: 32504083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced magnetic resonance imaging for evaluating fibrosis regression in chronic hepatitis C patients after direct-acting antiviral.
    Li XH; Huang R; Yang M; Wang J; Gao YH; Jin Q; Ma DL; Wei L; Rao HY
    World J Gastroenterol; 2022 May; 28(20):2214-2226. PubMed ID: 35721884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained virological response: a milestone in the treatment of chronic hepatitis C.
    Morisco F; Granata R; Stroffolini T; Guarino M; Donnarumma L; Gaeta L; Loperto I; Gentile I; Auriemma F; Caporaso N
    World J Gastroenterol; 2013 May; 19(18):2793-8. PubMed ID: 23687416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver Fibrosis Evaluation Using Real-time Shear Wave Elastography in Hepatitis C-Monoinfected and Human Immunodeficiency Virus/Hepatitis C-Coinfected Patients.
    Verlinden W; Bourgeois S; Gigase P; Thienpont C; Vonghia L; Vanwolleghem T; Michielsen P; Francque S
    J Ultrasound Med; 2016 Jun; 35(6):1299-308. PubMed ID: 27151906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection.
    Kirk GD; Astemborski J; Mehta SH; Spoler C; Fisher C; Allen D; Higgins Y; Moore RD; Afdhal N; Torbenson M; Sulkowski M; Thomas DL
    Clin Infect Dis; 2009 Apr; 48(7):963-72. PubMed ID: 19236273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic hepatitis C infection - Noninvasive assessment of liver fibrosis in the era of direct acting antivirals.
    Trivedi HD; Patwardhan VR; Malik R
    Dig Liver Dis; 2019 Feb; 51(2):183-189. PubMed ID: 30553749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of liver fibrosis by noncommercial serum markers in comparison with transient elastography in patients with chronic hepatitis C virus infection receiving direct-acting antiviral treatment.
    Knop V; Hofmann WP; Buggisch P; Klinker H; Mauss S; Günther R; Hinrichsen H; Hüppe D; Pfeiffer-Vornkahl H; Simon KG; Berg T; Manns MP; Friedrich-Rust M;
    J Viral Hepat; 2019 Feb; 26(2):224-230. PubMed ID: 30315694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced liver fibrosis score as a noninvasive biomarker in hepatitis C virus patients after direct-acting antiviral agents.
    Cossiga V; La Civita E; Bruzzese D; Guarino M; Fiorentino A; Sorrentino R; Pontillo G; Vallefuoco L; Brusa S; Montella E; Terracciano D; Morisco F; Portella G
    Front Pharmacol; 2022; 13():891398. PubMed ID: 36059971
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of serum autotaxin levels with liver fibrosis in patients pretreatment and posttreatment with chronic hepatitis C.
    Takemura K; Takizawa E; Tamori A; Nakamae M; Kubota H; Uchida-Kobayashi S; Enomoto M; Kawada N; Hino M
    J Gastroenterol Hepatol; 2021 Jan; 36(1):217-224. PubMed ID: 32453907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive assessment of fibrosis regression and portal hypertension in patients with advanced chronic hepatitis C virus (HCV)-associated liver disease and sustained virologic response (SVR): 3 years follow-up of a prospective longitudinal study.
    Knop V; Hoppe D; Vermehren J; Troetschler S; Herrmann E; Vermehren A; Friedrich-Rust M; Sarrazin C; Trebicka J; Zeuzem S; Welker MW
    J Viral Hepat; 2021 Nov; 28(11):1604-1613. PubMed ID: 34342081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elastography is unable to exclude cirrhosis after sustained virological response in HCV-infected patients with advanced chronic liver disease.
    Broquetas T; Herruzo-Pino P; Mariño Z; Naranjo D; Vergara M; Morillas RM; Forns X; Carrión JA
    Liver Int; 2021 Nov; 41(11):2733-2746. PubMed ID: 34525253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive assessment of liver fibrosis in patients with hepatitis C: Shear wave elastography and colour Doppler velocity profile technique versus liver biopsy.
    Moustafa EF; Makhlouf N; Hassany SM; Helmy A; Nasr A; Othman M; Seif H; Darwish M; Hassan H; Hessen M
    Arab J Gastroenterol; 2017 Mar; 18(1):6-12. PubMed ID: 28262531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.